Article
Disconnect Between Genes Associated With Ischemic Heart Disease and Targets of Ischemic Heart Disease Treatments.
EBioMedicine - 1 Feb 2018
Schooling C M, Huang J V, Zhao J V, Kwok M K, Au Yeung S L, Lin S L
Abstract excerpt
BACKGROUND: Development of pharmacological treatments to mitigate ischemic heart disease (IHD) has encompassed disappointing results and expensive failures, which has discouraged investment in new approaches to prevention and control. New treatments are most likely to be successful if they act on genetically validated targets. We assessed whether existing pharmacological treatments for IHD reduction are acting on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
